Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.72 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.72 |
| ▸ | HDAC4 | P56524 | 18/20 | 0.60 |
| ▸ | HDAC1 | Q13547 | 18/20 | 0.60 |
| ▸ | HDAC11 | Q96DB2 | 18/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 18/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 18/20 | 0.60 |
| ▸ | HDAC5 | Q9UQL6 | 18/20 | 0.60 |
| ▸ | HDAC7 | Q8WUI4 | 17/20 | 0.60 |
| ▸ | HDAC9 | Q9UKV0 | 17/20 | 0.60 |
| ▸ | HDAC3 | O15379 | 17/20 | 0.60 |
| ▸ | HDAC2 | Q92769 | 17/20 | 0.60 |
| ▸ | HDAC10 | Q969S8 | 17/20 | 0.60 |
| ▸ | NCOR1 | O75376 | 2/20 | 0.60 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | BRD4 | O60885 | 1/20 | 0.60 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.60 |
| ▸ | EGFR | P00533 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27097987 | 0.84 | CYP3A4 (1.00) | CYP3A4KCNH2CYP2C9HDAC4HDAC1 | |
| SCHEMBL10198760 | 0.83 | HDAC1 (0.66) | CYP3A4KCNH2CYP2C9HDAC4HDAC1 | |
| Hydroxyamine SCHEMBL1268824 | 0.82 | HDAC6 (0.79) | CYP3A4KCNH2HDAC4HDAC1HDAC11 | |
| SCHEMBL1065393 | 0.82 | HDAC4 (0.85) | CYP3A4KCNH2HDAC4HDAC1HDAC11 | |
| SCHEMBL6669511 | 0.82 | HDAC4 (0.85) | CYP3A4KCNH2HDAC4HDAC1HDAC11 | |
| SCHEMBL137348 | 0.82 | HDAC4 (0.85) | CYP3A4KCNH2HDAC4HDAC1HDAC11 | |
| SCHEMBL6665592 | 0.82 | HDAC4 (0.85) | CYP3A4KCNH2HDAC4HDAC1HDAC11 | |
| SCHEMBL8282876 | 0.81 | HDAC4 (0.63) | CYP3A4KCNH2CYP2C9HDAC4HDAC1 | |
| SCHEMBL21710531 | 0.81 | HDAC1 (0.64) | CYP3A4KCNH2CYP2C9HDAC4HDAC1 | |
| SCHEMBL517309 | 0.80 | HDAC4 (0.81) | CYP3A4KCNH2HDAC4HDAC1HDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210128740-A1 | HDAC INHIBITORS-BASED ANTIBODY DRUG CONJUGATES (ADCs) AND USE IN THERAPY | ALFASIGMA S.P.A. (IT) | 2021-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210128740-A1 | HDAC INHIBITORS-BASED ANTIBODY DRUG CONJUGATES (ADCs) AND USE IN THERAPY | ERBB3, HDAC6, ERBB2 | CYP3A4 3758/4885KCNH2 4692/4885CYP2C9 3436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.